Nandrolone
Specifications
434-22-0CAS Number
207-101-0EC Number
(8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-oneIUPAC Name
C18H26O2Chemical Formula
274.4 g/molMolecular Weight
nandrolone; 19-Nortestosterone; 434-22-0; Nortestosterone; Norandrostenolone; 19-Norandrostenolone; Menidrabol; Nortestonate; Nandrolon; Oestrenolon; Norandrostenolon; 17beta-Hydroxy-4-estren-3-one; 4-Estren-17beta-ol-3-one; Nandrolona; Nandrolonum; 17beta-Hydroxy-19-nor-4-androsten-3-one; (17beta)-17-hydroxyestr-4-en-3-one; decadura; Nandrolone cIII; DTXSID7023350; Estr-4-en-3-one, 17beta-hydroxy-; Estr-4-en-3-one, 17-hydroxy-, (17beta)-; BIOBOL; 6PG9VR430D; (8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one; NSC-3351; CHEBI:7466; DTXCID403350; Estrenolone; 17-Hydroxy-Estr-4-Ene-3-One; NSC3351; Nortestrionate; (8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthren-3-one; 17beta Hydroxy 19 Nor 4 Androsten 3 One; RefChem:831718; A14AB01; S01XA11; 207-101-0; 17beta-hydroxyestr-4-en-3-one; Nortestosteronum; 17-beta-Hydroestr-4-en-3-one; (17-beta)-17-Hydroxyestr-4-en-3-one; Nandrolone (INN); Nandrolone [INN]; CHEMBL757; (+)-19-Nortestosterone; NSC 3351; NCGC00159416-02; U 2410; Nandrolonum [INN-Latin]; Nandrolona [INN-Spanish]; decadura (TN); CAS-434-22-0; Nandrolone (1.0 mg/mL in Acetonitrile); SMR000058610; HSDB 3368; Nandrolone [INN:BAN]; EINECS 207-101-0; 4-Estren-17.beta.-ol-3-one; UNII-6PG9VR430D; Nandrolone Base; Nandrolone, beta; Estr-4-en-3-one, 17-hydroxy-, (17b)-; Nandrolone, alpha; NCGC00164479-01; Nandrolone Decanoate EP Impurity D; 19-nor-testosterone; Estr-4-en-3-one, 17-beta-hydroxy-; 17.beta.-Nandrolone; NANDROLONE [MI]; Nandrolone Decanoic acid; Estr-4-en-3-one, 17-hydroxy-, (17.beta.)-; enta[a]phenanthren-3-one; NANDROLONE [HSDB]; 17.beta.-Nortestosterone; NANDROLONE [VANDF]; EC 207-101-0; NANDROLONE [MART.]; Estr-4-en-3-one, 17-hydroxy-, (17-beta)-; NANDROLONE [WHO-DD]; SCHEMBL20140; MLS001423989; MLS002222325; orb401923; 17-Hydroxyestr-4-en-3-one; GTPL6949; Nandrolone, 1mg/ml in Methanol; Deca-Durabolin (decanoate ester); MSK2274; NANDROLONE CIII [USP-RS]; Durabolin (phenylpropionate ester); HMS2051I04; HMS2098E05; HMS2272P06; HMS3715E05; Tox21_113167; Tox21_113199; Tox21_201212; BDBM50080092; LMST02010044; MSK2274-100A; AKOS015894933; MSK2274-1000A; Nandrolone (1 mg/mL in Acetonitrile); Nandrolone 1.0 mg/ml in Acetonitrile; Tox21_113167_1; CCG-100835; CS-1416; DB13169; GS-6819; NC00085; ST 18:2;O2; 4-ESTREN-3-ONE-17.BETA.-OL; NCGC00159416-03; NCGC00159416-04; NCGC00258764-01; AC-15207; AC-30575; CPD000058610; HY-17432; 19-Nortestosterone, >=99.0% (HPLC); NS00008687; C07254; D08250; Nandrolone, VETRANAL(TM), analytical standard; Q421709; SR-01000781257; Nortestosterone Solution in Acetonitrile, 1000ug/mL; Nortestosterone Solution in Acetonitrile, 100ug/mL; SR-01000781257-3; W-106227; BRD-K52080565-001-09-2; NANDROLONE DECANOATE IMPURITY D [EP IMPURITY]; Nandrolone, British Pharmacopoeia (BP) Reference Standard; Nandrolone, United States Pharmacopeia (USP) Reference Standard; (1S,2R,10R,11S,14S,15S)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one; (8~{R},9~{S},10~{R},13~{S},14~{S},17~{S})-13-methyl-17-oxidanyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1~{H}-cyclop; (8~{R},9~{S},10~{R},13~{S},14~{S},17~{S})-13-methyl-17-oxidanyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1~{H}-cyclop enta[a]phenanthren-3-one; (8R,10R,13S,17S)-17-Hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one; (8R,9S,10R,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; 6VWSynonyms
